Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) — Cash Flow Quality Index
Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a Cash Flow Quality Index of -3.03x as of September 2025. Operating cash flow of CN¥-15.07 Million is below net income of CN¥4.97 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangsu Lianhuan Pharmaceutical Co Ltd Cash Flow Quality Index (2002–2024)
Historical Cash Flow Quality Index for Jiangsu Lianhuan Pharmaceutical Co Ltd across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 600513 cash generation efficiency.
Annual Cash Flow Quality Index for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
Year-by-year earnings quality comparison for Jiangsu Lianhuan Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥10.77 Million | CN¥106.42 Million | ▼ -90.5% |
| 2023 | 1.06x | CN¥160.70 Million | CN¥151.34 Million | ▲ +38.5% |
| 2022 | 0.77x | CN¥127.59 Million | CN¥166.44 Million | ▼ -22.5% |
| 2021 | 0.99x | CN¥138.34 Million | CN¥139.90 Million | ▲ +29.2% |
| 2020 | 0.77x | CN¥91.94 Million | CN¥120.15 Million | ▲ +745.4% |
| 2019 | -0.12x | CN¥-9.87 Million | CN¥83.25 Million | ▲ +90.4% |
| 2018 | -1.24x | CN¥-92.00 Million | CN¥74.17 Million | ▼ -2507.0% |
| 2017 | 0.05x | CN¥3.64 Million | CN¥70.56 Million | ▼ -95.4% |
| 2016 | 1.12x | CN¥70.28 Million | CN¥62.53 Million | ▼ -9.5% |
| 2015 | 1.24x | CN¥62.12 Million | CN¥50.01 Million | ▼ -21.5% |
| 2014 | 1.58x | CN¥69.50 Million | CN¥43.89 Million | ▲ +63.2% |
| 2013 | 0.97x | CN¥37.17 Million | CN¥38.32 Million | ▲ +64.1% |
| 2012 | 0.59x | CN¥16.94 Million | CN¥28.66 Million | ▼ -39.6% |
| 2011 | 0.98x | CN¥24.00 Million | CN¥24.51 Million | ▲ +135.1% |
| 2010 | 0.42x | CN¥8.43 Million | CN¥20.24 Million | ▼ -51.1% |
| 2009 | 0.85x | CN¥13.83 Million | CN¥16.24 Million | ▼ -36.7% |
| 2008 | 1.35x | CN¥17.44 Million | CN¥12.96 Million | ▲ +65.9% |
| 2007 | 0.81x | CN¥8.03 Million | CN¥9.90 Million | ▼ -36.8% |
| 2006 | 1.28x | CN¥10.14 Million | CN¥7.90 Million | ▲ +147.1% |
| 2005 | 0.52x | CN¥3.82 Million | CN¥7.36 Million | ▲ +10.2% |
| 2004 | 0.47x | CN¥3.39 Million | CN¥7.20 Million | ▲ +139.6% |
| 2003 | -1.19x | CN¥-13.19 Million | CN¥11.09 Million | ▼ -197.7% |
| 2002 | 1.22x | CN¥19.22 Million | CN¥15.78 Million | — |